Company intelligence / Profile preview
TiCARos Therapeutics
Seoul, Seoul, Koreapmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TiCARos has advanced its lead program TC011 into Phase I trials targeting lymphoma with promising preclinical data showing full tumor regression at low doses. The company’s proprietary platforms aim to overcome current limitations of conventional CAR-T therapies—especially in solid tumors—by improving efficacy and safety through novel engineering approaches. Additional programs are advancing through preclinical development targeting both hematologic malignancies and solid tumors.
- Therapeutic areas
- Oncology
- Modalities
- Autologous CAR-T cell therapy (Chimeric Antigen Receptor T cells)Proprietary next-generation CAR-T platforms (CLIP-CAR, Converter CAR, Switchable CAR)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Cartherics Pty Ltd. – collaborative research agreement focused on combining proprietary CLIP-CAR constructs with Cartherics’ NK cell platform for cancer immunotherapy applications.Selected by JLabs Korea/J&J support program in late–2024.KDDF Challenge awardee for solid cancer-targeting ‘CAR-T’ project in late–2024.
Beyond the preview
Go deeper on TiCARos Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TiCARos Therapeutics.